Skip to main content
SHANGHAI MODEL ORGANISMS CENTER, INC. logo

SHANGHAI MODEL ORGANISMS CENTER, INC. — Investor Relations & Filings

Ticker · 688265 ISIN · CNE1000055L1 LEI · 98450087AQ0IODE1EB16 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 544 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688265

About SHANGHAI MODEL ORGANISMS CENTER, INC.

https://www.modelorg.com/

Shanghai Model Organisms Center, Inc. (SMOC) specializes in the research, development, and application of genetically modified animal models for life science research and drug discovery. The company utilizes advanced gene-editing technologies, including CRISPR/Cas9 and embryonic stem cell targeting, to produce a wide range of genetically engineered mouse models (GEMMs), such as knockout, knockin, and conditional knockout strains. SMOC maintains an extensive repository of standardized models and offers customized model generation services tailored to specific research needs. Key offerings include humanized mouse models for immuno-oncology and inflammation studies, as well as comprehensive phenotyping and preclinical efficacy testing services. Serving a global clientele of pharmaceutical firms and academic institutions, the company provides critical tools for understanding disease mechanisms and accelerating therapeutic development.

Recent filings

Filing Released Lang Actions
关于2025年限制性股票激励计划首次授予部分第一个归属期第一批归属结果公告
Regulatory Filings Classification · 75% confidence The document is a regulatory announcement by Shanghai Nanfang Model Biotechnology Co., Ltd. on the Shanghai Stock Exchange, detailing the completion of the first vesting batch under its 2025 restricted stock incentive plan. It is not an annual or quarterly report, nor an earnings release, proxy, M&A filing, or dividend notice. It is a compliance/announcement document about equity incentive vesting results that does not fit more specific categories (e.g., share issue, director dealing, or remuneration proxy materials). Therefore it falls into the general Regulatory Filings category (RNS).
2026-05-26 Chinese
北京市通商律师事务所关于上海南方模式生物科技股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 75% confidence The document is a formal legal opinion (“法律意见书”) issued by a law firm regarding the convening, procedures, attendee qualifications, voting process, and results of the company’s 2025 annual general meeting. It is not the AGM materials themselves (AGM-R), nor a simple announcement of vote results (DVA), and contains no substantive financial statements or presentations. There is no dedicated category for a legal opinion letter, so it defaults to the general regulatory/fallback category for compliance documents and legal certifications.
2026-05-18 Chinese
2026年员工持股计划第一次持有人会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is an official announcement of the resolutions passed at the first holders meeting of the company’s 2026 employee share ownership plan, complete with detailed voting results for each proposal (approve/reject/abstain). This matches the definition of a Declaration of Voting Results & Voting Rights Announcement, which covers official results from shareholder (or plan-holder) votes at a meeting. Therefore, the appropriate classification is DVA.
2026-05-18 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is the announcement of the resolutions and voting results from the 2025 Annual General Meeting (AGM) of Shanghai Nanfang Mode BioTechnology Co., Ltd. It details meeting attendance, proposal names, vote counts, percentages, and confirmation by legal counsel. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” for an AGM. Therefore, it should be classified as DVA.
2026-05-18 Chinese
2025年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled '2025年度独立董事述职报告' which translates to '2025 Annual Independent Director's Work Report'. It contains detailed descriptions of the independent directors' duties, attendance at board and shareholder meetings, committee participation, communication with auditors, and oversight of financial reports and governance matters for the year 2025. The document is lengthy (15,000 characters) and contains substantive content about management and board activities, including nominations, remuneration, and internal controls. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement or certification. It is a detailed report by independent directors on their management and governance activities during the year, which fits the category of Board/Management Information (MANG).
2026-04-26 Chinese
上海市锦天城律师事务所关于上海南方模式生物科技股份有限公司限制性股票激励计划归属及作废相关事项之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's restricted stock incentive plans, specifically about the cancellation and vesting of certain restricted stocks under the 2022 and 2025 stock incentive plans. It discusses legal compliance, approvals, authorizations, and detailed conditions related to stock incentives. There is no indication that this is a financial report, earnings release, or management discussion. It is not a regulatory announcement or a proxy solicitation but a legal opinion on stock incentive matters. This fits best under the category of Regulatory Filings (RNS) as it is a legal opinion document related to corporate governance and compliance but does not fit other more specific categories like Board/Management Information or Remuneration Information. The document length and detail confirm it is not a brief announcement but a substantive legal opinion letter.
2026-04-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.